Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.


Demircan N., Dane F. , Ozturk M. A. , Besiroglu M., Babacan N., Kaya S., ...Daha Fazla

53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35 identifier